Arkolith/Insider Trading/RPRX/Form 4

Coyne Terrance P.

EVP & CFORoyalty Pharma plc (RPRX) · full profile →Form 4 · filed Jan 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.7M
Net Open-Market Flow
-$2.7M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2026Sell(S)4K$38.42$144K40K
Jan 2, 2026Sell(S)66K$38.42$2.5M461K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001814876-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML